News | Page 6 | Loda Lab

2024 Multi-Institutional Prostate SPORE Retreat in Los Angeles

March 8, 2024

On 3-5 March 2024, our Lab participated in the 2024 Multi-Institutional Prostate Cancer Program Retreat at the Luskin Center, UCLA, Los Angeles.

This retreat focused on advancements in Prostate Cancer research funded by the National Cancer Institute's (NCI) Specialized Programs of Research Excellence (SPORE) program. SPORE programs bring together researchers from different institutions to accelerate progress against specific cancers, including prostate cancer. The ultimate goal...

Dr. Nuzzo wins Best Poster Award at ESMO Targeted Anticancer Therapies Congress 2024

March 1, 2024

Dr. Pier Vitale Nuzzo has been recognized for their outstanding work at the recent ESMO Targeted Anticancer Therapies Congress (TAT) 2024 in Paris (26-28 February 2024).

Dr. Nuzzo received two prestigious awards - the ESMO Merit Travel Grant and the ESMO TAT Award for Best Poster - with the abstract "Targeting de novo lipogenesis synergizes with androgen receptor inhibitors in castration-resistant prostate cancer".

...

Our latest article has been covered on UroToday

February 2, 2024

Dr. Loda discusses with Dr. Andrea K. Miyahira (Director of Global Research & Scientific Communications, The Prostate Cancer Foundation) about our latest research article on the role of the microenvironment in prostate cancer progression, published in Nature Communications.

The study focuses on the stroma's significance in prostate carcinogenesis. Utilizing mouse models and human tumors, they performed single-cell RNA sequencing to analyze stromal...